Download This Bill in Microsoft Word format

Bill 1268

                    Current Status

Bill Number:                      1268
Type of Legislation:              Concurrent Resolution CR
Introducing Body:                 Senate
Introduced Date:                  20000321
Primary Sponsor:                  Moore
All Sponsors:                     Moore
Drafted Document Number:          l:\s-res\tlm\002anti.kad.doc
Date Bill Passed both Bodies:     20000426
Subject:                          Antibiotics, best practices for; CDC and 
                                  AAP recommendations endorsed; Medical, 
                                  Resolutions, Pharmacies


                        History

Body    Date      Action Description                     Com     Leg Involved
______  ________  ______________________________________ _______ ____________
Senate  20000426  Received from House
House   20000426  Adopted, returned to Senate with
                  concurrence
House   20000419  Committee report: Favorable            27 H3M
House   20000328  Introduced, referred to Committee      27 H3M
Senate  20000323  Adopted, sent to House
Senate  20000321  Introduced, placed on Calendar
                  without reference


              Versions of This Bill
Revised on March 21, 2000 - Word format
Revised on April 19, 2000 - Word format

COMMITTEE REPORT

April 19, 2000

S. 1268

S. Printed 4/19/00--H.

Read the first time March 28, 2000.

To whom was referred a Concurrent Resolution (S. 1268), to endorse the recommendations of the Centers for Disease Control and Prevention (CDC) and American Academy of Pediatrics (AAP) for health care professionals regarding the best practices, etc., respectfully

That they have duly and carefully considered the same, and recommend that the same do pass:

JOE E. BROWN, for Committee.

TO ENDORSE THE RECOMMENDATIONS OF THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) AND AMERICAN ACADEMY OF PEDIATRICS (AAP) FOR HEALTH CARE PROFESSIONALS REGARDING THE BEST PRACTICES FOR THE JUDICIOUS USE OF ANTIBIOTICS.

Whereas, antibiotic-resistant infections are more likely to produce adverse health outcomes and are more costly to treat than susceptible infections; and

Whereas, the widespread use of antibiotics has increased the type and incidence of bacteria that are resistant to treatment by antibiotics; and

Whereas, antibiotic resistance is caused by the overuse of antibiotics in general, with overuse of selected agents in particular; and

Whereas, over the past five years the rate of penicillin resistance increased by more than three hundred percent and the rate of cefotaxime resistance increased by more than one thousand percent; and

Whereas, patients infected with antibiotic-resistant strains of bacteria can require hospitalization when otherwise unnecessary and be subject to an increased rate of death; and

Whereas, the process of creating antibiotic-resistance increases pharmaceutical costs through inappropriate prescribing of antibiotic agents and increases total healthcare costs through the additional hospitalization and other forms of additional medical care required in the treatment of resistant strains of bacteria; and

Whereas, the federal Centers for Disease Control and Prevention (CDC) and American Academy of Pediatrics (AAP) have developed recommendations for health care professionals regarding the best practices for the judicious use of antibiotics. Now, therefore,

Be it resolved by the Senate, the House of Representatives concurring:

That the General Assembly of the State of South Carolina, by this resolution, endorses the CDC/AAP recommendations and urges each health care professional and managed care plan operating in the State to adopt the recommendations in their practice and formularies.

This web page was last updated on Wednesday, December 9, 2009 at 9:10 A.M.